Dr Frank Eperjesi, an optometry specialist at the School of Life & Health Sciences at Aston University in Birmingham, UK, will lead the study into whether neovascular age-related  macular degeneration (nAMD), a common condition affecting 321,000 people in England, Scotland and Wales, can be identified before patients begin to show symptoms of having the disease.